Gradient Investments’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$104M Buy
2,411,318
+90,999
+4% +$3.86M 1.44% 13
2026
Q1
$90.4M Buy
2,320,319
+118,334
+5% +$4.8M 1.4% 15
2025
Q4
$89.9M Buy
2,201,985
+63,805
+3% +$2.6M 1.43% 16
2025
Q3
$86.3M Buy
2,138,180
+106,454
+5% +$4.1M 1.44% 15
2025
Q2
$74.7M Buy
2,031,726
+23,591
+1% +$799K 1.37% 14
2025
Q1
$66.7M Buy
+2,008,135
New +$69.8M 1.35% 19

Other funds holding RECS

Gradient Investments's RECS Position: Q2 2026 in Review

Gradient Investments increased its Columbia Research Enhanced Core ETF (RECS) stake by 3.9% in Q2 2026, buying an estimated $3.86M and bringing the position to 2,411,318 shares worth $104M. The position accounts for 1.44% of the portfolio, ranked #13.

Gradient Investments first reported a position in RECS in Q1 2025 and has held it in 6 quarters since. 26 funds tracked by Wall St. Rank hold RECS as of Q2 2026.

  • Gradient Investments held 2,411,318 shares of Columbia Research Enhanced Core ETF worth $104M as of Q2 2026.
  • Gradient Investments bought 90,999 Columbia Research Enhanced Core ETF shares in Q2 2026, an estimated $3.86M.
  • Columbia Research Enhanced Core ETF made up 1.44% of Gradient Investments's portfolio in Q2 2026, its #13 holding.
  • Gradient Investments first reported a position in Columbia Research Enhanced Core ETF in Q1 2025 and has held it in 6 quarters since.
  • 26 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q2 2026.

Based on Gradient Investments's 13F filing for Q2 2026, filed 8 Jul 2026.